The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study
Open accessAbstract
We intended to identify the prognostic factors and the results of interventions on patients with liver metastatic midgut carcinoids. Five institutions that are part of United Kingdom and Ireland neuroendocrine tumour (NET) group took part in this study. Patients were included if they had histology proven NET of midgut origin and liver metastases at the time of the study. Clinical and biochemical data were collected retrospectively from hospital charts, pathology reports, radiology reports and biochemistry records for each patient. Three hundred and sixty patients were included in the study. The median survival from date of diagnosis was 7.69 years (confidence interval (CI) 6.40–8.99) and 5.95 years (CI 5.02–6.88) from date of diagnosis of liver metastases. On univariate analysis, increasing age at diagnosis, increasing urinary hydroxyindole acetic acid levels, increasing plasma chromogranin A levels, high Ki67, high tumour volume and treatment with chemotherapy were identified as factors associated with a significantly poorer outcome. Resection of liver metastases, resection of small bowel primary, treatment with somatostatin analogue therapy and treatment with peptide receptor therapy were associated with improved prognosis. Multivariate analysis revealed that age at diagnosis (P=0.014), Ki67 level (P=0.039) and resection of primary (P=0.015) were independent predictors of survival. This is the largest study to our knowledge looking specifically at the prognosis and clinical course of patients with liver metastatic midgut NETs. For the first time, we have shown that Ki67 and resection of primary are independent predictors of survival for this group of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Rinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
Kwekkeboom, D. J., de Herder, W. W., Kam, B. L., van Eijck, C. H., van Essen, M., Kooij, P. P., Feelders, R. A., van Aken, M. O., & Krenning, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2553 · Cited by 1,456
Rindi, G., Klöppel, G., Couvelard, A., Komminoth, P., Körner, M., Lopes, J. M., McNicol, A.-M., Nilsson, O., Perren, A., Scarpa, A., et al. (2007) · Virchows Archiv · doi:10.1007/s00428-007-0452-1 · Cited by 955
Treatment of the Malignant Carcinoid Syndrome
Kvols, L. K., Moertel, C. G., O'Connell, M. J., Schutt, A. J., Rubin, J., & Hahn, R. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151102 · Cited by 849
Current Status of Gastrointestinal Carcinoids
Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 848
Sarmiento, J. M., Heywood, G., Rubin, J., Ilstrup, D. M., Nagorney, D. M., & Que, F. G. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00230-8 · Cited by 773
Hepatic neuroendocrine metastases: does intervention alter outcomes?1
Chamberlain, R. S., Canes, D., Brown, K. T., Saltz, L., Jarnagin, W., Fong, Y., & Blumgart, L. H. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00222-2 · Cited by 622
Life history of the carcinoid tumor of the small intestine
Moertel, C. G., Sauer, W. G., Dockerty, M. B., & Baggenstoss, A. H. (1961) · Cancer · doi:10.1002/1097-0142(196109/10)14:5<901::aid-cncr2820140502>3.0.co;2-q · Cited by 555
Faiss, S., Pape, U.-F., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W., Riecken, E. O., & Wiedenmann, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 501
The American journal of surgical pathology
Wilkins, L. W. (1977) · Cited by 501
Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center
Janson, E. T., Holmberg, L., Stridsberg, M., Eriksson, B., Theodorsson, E., Wilander, E., & öberg, K. (1997) · Annals of Oncology · doi:10.1023/a:1008215730767 · Cited by 455
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
Waldherr, C., Pless, M., Maëcke, H. R., Schumacher, T., Crazzolara, A., Nitzsche, E. U., Haldemann, A. R., & Mueller‐Brand, J. (2002) · PubMed · Cited by 445
Kennedy, A. S., Dezarn, W. A., McNeillie, P., Coldwell, D., Nutting, C., Carter, D., Murthy, R., Rose, S., Warner, R. R. P., Liu, D., et al. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815e4557 · Cited by 424
Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours
Pape, U.-F., Berndt, U., Muller-Nordhorn, J., Bohmig, M., Roll, S., Koch, M., Willich, S. N., & Wiedenmann, B. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0017 · Cited by 384
Cytoreductive hepatic surgery for neuroendocrine tumors.
Gp, M., Nagorney, D. M., Lk, K., Cg, M., & Cs, G. (1990) · PubMed · Cited by 381
Sun, W., Lipsitz, S., Catalano, P., Mailliard, J. A., & Haller, D. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.616 · Cited by 357
European Journal of Gastroenterology & Hepatology
&NA; (2000) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200012061-00008 · Cited by 337
Di Bartolomeo, M., Bajetta, E., Buzzoni, R., Mariani, L., Carnaghi, C., Somma, L., Zilembo, N., Di Leo, A., & ITMO Association (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<402::aid-cncr25>3.0.co;2-4 · Cited by 296
BURKE, A. P., Thomas, R. M., Elsayed, A. M., et al. (1997) · PubMed · Cited by 244
The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors
Ducreux, M. (2000) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02003-7 · Cited by 196
Arnold, R., Müller, H., Schade-Brittinger, C., Rinke, A., Klose, K., Barth, P., Wied, M., Mayer, C., Aminossadati, B., & PROMID Study Group (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.4508 · Cited by 192
Eriksson, B., Renstrup, J., Imam, H., & Öberg, K. (1997) · Annals of Oncology · doi:10.1023/a:1008205415035 · Cited by 190
Rosenau, J., Bahr, M. J., von Wasielewski, R., Mengel, M., Schmidt, H. H. J., Nashan, B., Lang, H., Klempnauer, J., Manns, M. P., & Boeker, K. H. W. (2002) · Transplantation · doi:10.1097/00007890-200202150-00012 · Cited by 188
Surgical treatment of mid‐gut carcinoid tumors
Makridis, C., Öberg, K., Juhlin, C., Rastad, J., Johansson, H., Lörelius, L. E., & Åkerström, G. (1990) · World Journal of Surgery · doi:10.1007/bf01658532 · Cited by 161
Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut
Strosberg, J., Gardner, N. M., & Kvols, L. K. (2009) · Neuroendocrinology · doi:10.1159/000197899 · Cited by 151
Kress, O., Wagner, H., Wied, M., Klose, K.-J., Arnold, R., & Alfke, H. (2003) · Digestion · doi:10.1159/000074522 · Cited by 150
Welin, S., Janson, E., Sundin, A., Stridsberg, M., Lavenius, E., Granberg, D. O., Skogseid, B. M., Öberg, K., & Eriksson, B. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510107 · Cited by 133
Circulating markers of prognosis and response to treatment in patients with midgut carcinoid tumours
Turner, G. B., Johnston, B. T., McCance, D. R., et al. (2006) · Gut · doi:10.1136/gut.2006.092320 · Cited by 123
Self-citationArdill, J. E. S., & Erikkson, B. (2003) · Endocrine Related Cancer · doi:10.1677/erc.0.0100459 · Cited by 103
Self-citationManagement of midgut carcinoids
Åkerström, G., Hellman, P., Hessman, O., & Osmak, L. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20188 · Cited by 102
Treatment of Malignant Midgut Carcinoid Tumours with A Long-Acting Somatostatin Analogue Octreotide
Öberg, K., Norheim, I., & Theodorsson, E. (1991) · Acta Oncologica · doi:10.3109/02841869109092409 · Cited by 80
Treatment of Neuroendocrine Tumours in Adults with 131I-MIBG Therapy
Bomanji, J. B., Wong, W., Gaze, M. N., Cassoni, A., Waddington, W., Solano, J., & Ell, P. J. (2003) · Clinical Oncology · doi:10.1016/s0936-6555(02)00273-x · Cited by 55
Jacobsen, M. B., & Hanssen, L. E. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01175.x · Cited by 46
Endocrine Tumors of the Ileum: Factors Correlated with Survival
Tomassetti, P., Campana, D., Piscitelli, L., Casadei, R., Nori, F., Brocchi, E., Santini, D., Pezzilli, R., & Corinaldesi, R. (2006) · Neuroendocrinology · doi:10.1159/000096053 · Cited by 42
Søndenaa, K., Sen, J., Heinle, F., Fjetland, L., Gudlaugsson, E. G., & Syversen, U. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7384-6 · Cited by 28
Cited by
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Self-citationPavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Öberg, K., Knigge, U., Kwekkeboom, D., & Perren, A. (2012) · Annals of Oncology · doi:10.1093/annonc/mds295 · Cited by 524
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum
Niederle, B., Pape, U.-F., Costa, F., Gross, D., Kelestimur, F., Knigge, U., Öberg, K., Pavel, M., Perren, A., Toumpanakis, C., et al. (2016) · Neuroendocrinology · doi:10.1159/000443170 · Cited by 474
Pape, U.-F., Perren, A., Niederle, B., Gross, D., Gress, T., Costa, F., Arnold, R., Denecke, T., Plöckinger, U., Salazar, R., et al. (2012) · Neuroendocrinology · doi:10.1159/000335629 · Cited by 465
Metadata
- Authors
- Ahmed, A., Turner, G., King, B., Jones, L., Culliford, D., McCance, D., Ardill, J., Johnston, B. T., Poston, G., Rees, M., Buxton-Thomas, M., Caplin, M., & Ramage, J. K.
- Venue
- Endocrine-Related Cancer
- Publisher
- Bioscientifica
- Published
- 2009-09
- Volume
- 16
- Issue
- 3
- Pages
- 885-894
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2100296588
- Cited by
- 274
- References
- 36
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.